drugset / Trial / NCT03164291
Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex
Phase 3
Completed
170 enrolled
The University of Texas Health Science Center at Tyler
Pfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
Treatment of adults with chronic Mycobacterium avium-intracellulare complex lung infections who have failed or are intolerant of rifampin. Rifabutin may be a reasonable alternative agent in patients who fail rifampin or or intolerant of rifampin.
Timeline
- Start
- 1984-06
- Primary completion
- 2006-09
- Completion
- 2017-05-18